These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1463870)

  • 1. A bioassay for antiestrogenic activity--potential utility in drug development and monitoring effective in vivo dosing.
    DeGregorio M; Wurz G; Emshoff V; Koester S; Minor P; Wiebe V
    Breast Cancer Res Treat; 1992; 24(1):35-41. PubMed ID: 1463870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB
    Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry: potential utility in monitoring drug effects in breast cancer.
    Koester SK; Maenpaa JU; Wiebe VJ; Baker WJ; Wurz GT; Seymour RC; Koehler RE; DeGregorio MW
    Breast Cancer Res Treat; 1994; 32(1):57-65. PubMed ID: 7819587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.
    Grenman R; Laine KM; Klemi PJ; Grenman S; Hayashida DJ; Joensuu H
    J Cancer Res Clin Oncol; 1991; 117(3):223-6. PubMed ID: 1827796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
    Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
    Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.
    Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC
    Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L; Nieminen AL; Cantell K
    Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59).
    Shibata J; Toko T; Saito H; Lykkesfeldt AE; Fujioka A; Sato K; Hashimoto A; Wierzba K; Yamada Y
    Cancer Chemother Pharmacol; 2000; 45(2):133-41. PubMed ID: 10663628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
    Mäenpää JU; Ala-Fossi SL
    Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
    di Salle E; Zaccheo T; Ornati G
    J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the pharmacological properties of toremifene.
    Kangas L
    J Steroid Biochem; 1990 Jun; 36(3):191-5. PubMed ID: 2142231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic potency of toremifene and tamoxifen in postmenopausal women.
    Homesley HD; Shemano I; Gams RA; Harry DS; Hickox PG; Rebar RW; Bump RC; Mullin TJ; Wentz AC; O'Toole RV
    Am J Clin Oncol; 1993 Apr; 16(2):117-22. PubMed ID: 8452102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.
    DeGregorio MW; Ford JM; Benz CC; Wiebe VJ
    J Clin Oncol; 1989 Sep; 7(9):1359-64. PubMed ID: 2527971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
    Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
    Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen and the derivative (TAT) on cell cycle of MCF-7 in vitro.
    Tominaga T; Yoshida Y; Matsumoto A; Hayashi K; Kosaki G
    Anticancer Res; 1993; 13(3):661-5. PubMed ID: 8317894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
    Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and biochemical pharmacology of toremifene, an antiestrogenic antitumor drug.
    Kangas L
    Acta Obstet Gynecol Scand; 1991; 70(4-5):399. PubMed ID: 1836089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antitumor activity of a new antiestrogenic drug, toremifene (NK622) against human breast cancer xenografts in nude mice].
    Kuroiwa S; Koyama M; Watanabe N; Ekimoto H; Ohnishi Y; Saito M; Maruo K; Inaba M; Tashiro T; Yamori T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):617-23. PubMed ID: 8470919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.